Latest Breaking News On - Australian science media - Page 6 : comparemela.com
What to know about vaccine-related deaths, allergies
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Hayabusa2 mission confirms return of an asteroid sample, including gas, to Earth
1490wosh.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 1490wosh.com Daily Mail and Mail on Sunday newspapers.
Every new day brings new cases of the COVID-19 pandemic. Due to which people are bound to stay at home. So far, all the records have been broken. According to a report, around 70 million Coronavirus cases have been reported all over the world, and there are more than 1.5 million deaths so far. However, more than 49 million people have been recovered from this deadliest virus.
What more alarming is people do not have accurate and updated details about the precautions of COVID-19 and its vaccines. There is the good news that the vaccine for this deadliest virus is coming soon. Hopefully, this vaccine will help to stop this disease to a great extent. According to Google, people are given misinformation about this vaccine.
Science’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.
The backers of Australia’s homegrown COVID-19 vaccine candidate today announced a halt to its further development, after some of the first people to receive the vaccine in a safety trial generated antibodies to an unintended target, the AIDS virus. A small fragment of an HIV protein is a component of the vaccine used to add stability to the intended antibody target, the spike protein of the pandemic coronavirus SARS-CoV-2.
Although the added component didn’t represent an actual infection with HIV, the vaccine developers and the Australian government concluded a widespread rollout of the candidate would interfere with HIV diagnostic tests and decided not to proceed to larger clinical trials that would have measured its protection against COVID-19. Given the strong efficacy shown by several recent COVID-19 vaccines, it’s likely that other candidates still in development will no